围生期心肌病相关血清学标志物的研究进展

【摘要】围生期心肌病是一类罕见的围产期恶性心脏疾病，近年来发病率有升高趋势，但总体的相关研究报告较少。现对目前针对围生期心肌病相关血清学标志物的研究进行综述，从临床已开展检测的标志物和临床未开展检测的标志物两个角度进行描述。

【关键词】围生期心肌病；血清学；标志物

【DOI】1016806/j.cnki.issn.10043934202503012

Serological Markers Related to Peripartum Cardiomyopathy

ZHAO Xiaowei1，JIANG Lu2

（1.Department of Obstetrics and Gynecology，Dazu Hospital Affiliated to Chongqing Medical University，Chongqing 400900，China； 2.Department of General Medicine，Dazu Hospital Affiliated to Chongqing Medical University，Chongqing 400900，China）

【Abstract】Peripartum cardiomyopathy is a rare perinatal malignant heart disease.In recent years，the incidence rate has an upward trend，but there are few related research reports.This article provides a review of current research on serological markers for peripartum cardiomyopathy，describing them from two perspectives：markers that have been clinically tested and markers that have not been clinically tested.

【Keywords】Peripartum cardiomyopathy；Serology；Marker

围生期心肌病（peripartum cardiomyopathy， PPCM）是一种罕见的心脏疾病，其特征是妊娠最后1个月～分娩后5个月出现的左心室心肌功能障碍和/或左心室扩大［1］。（剩余11008字）